Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Massachusetts General Hospital
Sponsor:
Collaborators:
ALS Association
ALS Finding a Cure
Information provided by (Responsible Party):
James D. Berry MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01495390
First received: December 16, 2011
Last updated: June 2, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)